Light AI

Empower healthcare providers to make real-time diagnostic decisions and combat antibiotic resistance using AI-powered imaging on standard smartphone devices.

disease detection

About Light AI

Light AI is an emerging artificial intelligence platform dedicated to revolutionizing medical diagnostics at the point of care. Its primary mission is to differentiate between bacterial and viral infections using advanced imaging technology, specifically targeting common but impactful conditions like streptococcal pharyngitis (Strep A). By providing immediate clarity on the nature of an infection, the tool aims to reduce the global overprescription of antibiotics, which is a major driver of antimicrobial resistance (AMR). The platform leverages assistive AI to analyze visual data, turning common hardware into powerful diagnostic tools capable of delivering results in real-time. The technology operates by applying sophisticated machine learning algorithms to images captured via smart devices. Originally developed as a dedicated diagnostic device, the company pivoted during the COVID-19 pandemic to adapt its algorithms for use with smartphones. This transition allows for a non-invasive, fast diagnostic process that does not require traditional laboratory infrastructure or specialized medical hardware. In real-world validation trials, the system demonstrated a 96.7% detection accuracy for Strep A. The core functionality involves the analysis of visual markers that distinguish bacterial pathogens from viral ones, providing clinicians with high-confidence data for patient management. This platform is designed primarily for healthcare practitioners, including those in urban hospitals and rural clinics. Its scalability makes it particularly suitable for clinicians in emerging markets, such as Africa and India, where access to formal laboratory testing may be limited, expensive, or slow. By enabling swift decision-making, it helps providers manage infectious diseases more effectively and protect vital healthcare resources. It is also a critical tool for global health organizations and stakeholders focused on antibiotic stewardship and reducing the long-term economic and human toll of antimicrobial resistance. What sets Light AI apart is its focus on accessibility and the democratization of diagnostics through mobile integration. While many AI diagnostic tools require high-end proprietary equipment, Light AI’s ability to function on consumer-grade mobile devices provides a unique level of scalability for global health initiatives. Furthermore, the company’s specific focus on the bacterial-versus-viral distinction addresses one of the most pressing challenges in modern medicine—AMR—positioning it as a public health solution as much as a clinical diagnostic aid.

Light AI pros & cons

Pros

Achieves high accuracy of 96.7% in real-world Strep A detection trials.
Operates on standard smartphones, eliminating the need for specialized laboratory equipment.
Provides real-time results at the point of care for immediate clinical decision-making.
Supports global antibiotic stewardship by preventing unnecessary bacterial prescriptions.
Designed for high scalability in emerging markets like Africa and India.

Cons

Not yet cleared or approved by the U.S. FDA or Health Canada.
Currently unavailable for commercial or clinical use while undergoing validation.
Accuracy may be dependent on the quality of images captured via mobile cameras.

Light AI use cases

Rural healthcare providers can use smartphone-based diagnostics to identify Strep A without access to a physical laboratory.
Clinicians in emerging markets can utilize the tool to manage infectious diseases in underserved communities with limited resources.
Global health organizations can implement the platform to track and reduce the spread of antimicrobial resistance across borders.
Point-of-care practitioners can make immediate decisions on antibiotic prescriptions based on real-time bacterial vs. viral differentiation.
Healthcare systems can use the tool to reduce laboratory costs and improve patient throughput in overwhelmed clinics.

Light AI features

scalable global health platform
96.7% detection accuracy
strep a detection validation
non-invasive testing
real-time point-of-care analysis
smartphone-based diagnostics
bacterial vs. viral differentiation
assistive ai imaging

Light AI FAQs

Is Light AI currently available for clinical use?

No, Light AI products are currently undergoing clinical validation and have not been cleared or approved by the U.S. FDA, Health Canada, or other regulatory authorities. They are not yet available for commercial or clinical use.

What types of diseases can the tool identify?

The platform focuses on differentiating between bacterial and viral infections, with specific validation for Strep A and adaptations for COVID-19. It is designed to assist in the management of various infectious diseases through advanced imaging.

Do I need specialized equipment to use this technology?

No, the technology has been adapted for use with standard smartphones. This allows healthcare providers to perform diagnostics using the camera and processing power of a regular mobile device rather than expensive lab hardware.

How accurate is the diagnostic technology?

In real-world validation trials for Strep A detection, the technology achieved an accuracy rate of 96.7%. The AI algorithms have been refined through collaboration with institutions to create a robust database of viral and bacterial infection images.

How does this help with antibiotic resistance?

By accurately identifying whether an infection is bacterial or viral, it ensures antibiotics are only prescribed when clinically necessary. This prevents the misuse of drugs that leads to the development of resistant bacteria and increased healthcare costs.

Ratings & reviews

No reviews yet. Be the first to share how Light AI worked for you.